| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $686.6M | +25.9% |
| Cost of Revenue | $417.9M | +26.7% |
| Gross Profit | $268.8M | +24.6% |
| R&D Expense | $46.8M | +19.0% |
| SG&A Expense | $72.3M | +11.3% |
| Operating Income | -$45.5M | +18.9% |
| Interest Expense | $4.9M | +3.3% |
| Pre-tax Income | -$61.2M | -21.3% |
| Income Tax | $589K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.0M | -32.5% |
| Short-term Investments | $204.1M | -6.2% |
| Accounts Receivable | $97.4M | +31.6% |
| Inventory | $3.9M | +0.1% |
| Current Assets | $334.6M | +2.2% |
| Total Assets | $703.7M | +3.5% |
| Current Liabilities | $88.9M | +18.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.1M | +139.6% |
| Capital Expenditures | $30.2M | +66.8% |
| Investing Cash Flow | -$16.6M | +17.6% |
| Financing Cash Flow | $2.9M | -37.7% |
| Free Cash Flow | -$24.1M | +28.0% |
| +2904.8% |
| Net Income | -$61.7M | -22.5% |
| Total Liabilities |
| $427.0M |
| +17.1% |
| Stockholders' Equity | $275.6M | -12.4% |